In addition to EBV DNA, many biomarkers have been reported to be associated with the prognosis of NPC, such as EBV serum antibodies, miR-BART2-5p, serum LDH, and C-reactive protein (CRP) (37–40). The gene discussed is CRP; the disease is nasopharyngeal carcinoma.